Visuo-motor coordination is normal in patients with major depression

Parkinsonism and Related Disorders

Volumn 9, Issue 6, 2003, Pages 361-366

  Hocherman, Shraga ^a   Dimant, Alexander ^c   Schwartz, Miguel ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

^c NONE

Author keywords

Depression; Parkinson's disease; Visuo motor coordination

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; VISUOMOTOR COORDINATION;

EID: 0038692118     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(03)00017-8     Document Type: Article

References (28)

1. Poewe W., Seppi K. Treatment options for depression and psychosis in Parkinson's disease. J Neurol. 248:(suppl 3):2001;III12-III21.
2. Rampello L., Chiechio S., Raffaele R., Vecchio I., Nicoletti F. The SSRI, Citalopram improves bradykinesia in patients with Parkinson's disease treated with L-Dopa. Clin Neuropharmacol. 25:2002;21-24.
3. Shulman M.L., Taback R.L., Rabinstein A.A. Nonrecognition of depression and other non-motor symptoms in Parkinson's disease. Park Rel Disord. 8:2002;193-197.
4. Yamamoto M. Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background. J Neurol. 248:(suppl 3):2001;III5-II11.
5. Zesiewicz T.A., Hauser R.A. Depression in Parkinson's disease. Curr Psychiatry Rep. 4:2002;69-73.
6. Nilsson F.M., Kessing L.V., Bolwig T.G. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand. 104:2001;380-386.
7. Koller W.C. When does Parkinson's disease begin? Neurology. 42:1992;27-31.
8. Cubo E., Bernard B., Leurgans S., Raman R. Cognitive and motor function in patients with Parkinson's disease with and without depression. Clin Neuropharmacol. 23:2000;331-334.
9. Norman S., Troster A.I., Fields J.A., Brooks R. Effects of depression and Parkinson's disease on cognitive functioning. J Neuropsychiatry Clin Neurosci. 14:2002;31-36.
10. Landro N.I., Stiles T.C., Sletvold H. Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol. 14:2001;233-240.
11. Woodward T.S., Bub D.N., Hunter M.A. Task switching deficits associated with Parkinson's disease reflect depleted attentional resources. Neuropsychologia. 40:2002;1948-1955.
12. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol. 67:2002;53-83.
13. Mayeux R., Stern Y., Rosen J., Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology. 31:1981;645-650.
14. Jordan N., Sagar H.J., Cooper J.A. A component analysis of the generation and release of isometric force in Parkinson's disease. J Neurol Neurosurg Psychiatry. 55:1992;572-576.
15. Sackeim H.A., Freeman J., McElhiney M., Coleman E., Prudic J., Devanand D.P. Effects of major depression on estimates of intelligence. J Clin Exp Neuropsychol. 14:1992;268-288.
16. Hocherman S., Levy H. The role of feedback in manual tracking of visual targets. Perceptual Motor Skills. 90:2000;1235-1248.
17. Hocherman S. Quantitative clinical evaluation of Parkinsonism based on visuo-motor tracking and tracing. Prezuntek H., Kraus P.H., Klotz P., Korczyn A.D. Instrumental methods and scoring in extrapyramidal disorders. 1995;196-202 Springer, Berlin.
18. Hocherman S., Aharon-Peretz J. Two dimensional tracing and tracking in patients with Parkinson's disease. Neurology. 44:1994;111-116.
19. Hocherman S., Giladi N. Visuo-motor control abnormalities in patients with unilateral Parkinsonism. Neurology. 50:1998;1648-1654.
20. Schwartz M., Badarny S., Gofman S., Hocherman S. Visuo-motor performance in patients with essential tremor. Mov Disord. 14:(6):1999;988-993.
21. Silver H., Shlomo N., Schwartz M., Hocherman S. Visuo motor function is impaired in schizophrenia compared with controls. J Neuropsychiatry Clin Neurosci. 14:(1):2002;72-76.
22. Schwartz M., Badarny S., Hocherman S. Visuo-motor testing of neurological patients and differential diagnosis of Parkinson's disease. Mov Disord. 15:(s3):2000;849.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 12:1960;56-62.
24. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand. 212:(suppl):1970;11-19.
25. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand. 101:(1):2000;11-20.
26. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain. 124:2001;2503-2512.
27. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain. 114:1991;2095-2122.
28. Stoffers D., Berendse H.W., Deijen J.B., Wolters E.C. The influence of computer experience on visuo-motor control: implications for visuo-motor testing in Parkinson's disease. Neuropsychologia. 40:2002;1779-1785.